FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

MDA Signature Galas

Join us for a day or evening of progress! Let’s unite our communities and bring awareness to neuromuscular disease. Together with MDA, we will continue to lead the way in accelerating care, advancing research, and advocating for the support of families.

Event Schedule